Patient Conditions/Disease States

Understanding hATTR Amyloidosis: Clinical Presentation, Patient Journey, and Treatment Landscape for This Rare Disease

Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.
Payment Systems, Rare Diseases, Managed Care Practice Issues, Patient Conditions/Disease States, Rare Diseases

AMCP Partnership Forum on Rare Diseases Identifies Solutions to Prepare for and Manage Orphan Drugs and Gene Therapies

More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.
Patient Conditions/Disease States, Rare Diseases

AMCP Submits Comments in Response to PQA Endorsement Consideration of Two New Performance Measures: Concurrent Use of Opioids and Benzodiazepines and Adherence to Non-Infused Disease Modifying Agents Use to Treat Multiple Sclerosis

The Academy of Managed Care Pharmacy (AMCP) thanks the Pharmacy Quality Alliance (PQA) for the opportunity to provide comments in response to the Call for Comments on PQA Endorsement Consideration of Two New Performance Measures.
Patient Conditions/Disease States, Rare Diseases

PRIME Partners With AGA and AMCP on Hepatitis C Virus and Inflammatory Bowel Disease Educational Initiative

Press Release: PRIME Education, Inc. (PRIME), the American Gastroenterological Association (AGA), and the Academy of Managed Care Pharmacy (AMCP), are pleased to announce a groundbreaking initiative in collegial learning between payers and providers to improve treatment decision-making in chronic and costly gastroenterological (GI) diseases.
Patient Conditions/Disease States, Rare Diseases